Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE3.8800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.5100/ 1
- Ask / Lots4.0800/ 20
- Open / Previous Close0.0000 / 3.8800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 14879 | 3.94 |
| 09:34 ET | 1250 | 3.99 |
| 09:36 ET | 11746 | 4 |
| 09:38 ET | 5800 | 3.98 |
| 09:39 ET | 3393 | 3.955 |
| 09:41 ET | 4100 | 3.9671 |
| 09:43 ET | 2570 | 3.95 |
| 09:48 ET | 2000 | 3.955 |
| 09:50 ET | 1328 | 3.945 |
| 09:52 ET | 5036 | 3.9099 |
| 09:54 ET | 200 | 3.92 |
| 09:56 ET | 2250 | 3.9199 |
| 09:57 ET | 1800 | 3.91 |
| 09:59 ET | 3233 | 3.915 |
| 10:01 ET | 1000 | 3.915 |
| 10:03 ET | 4100 | 3.915 |
| 10:06 ET | 200 | 3.915 |
| 10:08 ET | 1458 | 3.925 |
| 10:10 ET | 883 | 3.925 |
| 10:12 ET | 635 | 3.925 |
| 10:14 ET | 1604 | 3.935 |
| 10:15 ET | 7570 | 3.915 |
| 10:17 ET | 1910 | 3.925 |
| 10:19 ET | 1200 | 3.925 |
| 10:21 ET | 1062 | 3.93 |
| 10:24 ET | 2872 | 3.935 |
| 10:26 ET | 934 | 3.94 |
| 10:28 ET | 6698 | 3.935 |
| 10:30 ET | 700 | 3.935 |
| 10:32 ET | 4277 | 3.936 |
| 10:33 ET | 700 | 3.935 |
| 10:35 ET | 900 | 3.94 |
| 10:37 ET | 200 | 3.93 |
| 10:39 ET | 1400 | 3.94 |
| 10:42 ET | 14177 | 3.93 |
| 10:44 ET | 2520 | 3.895 |
| 10:46 ET | 722 | 3.88 |
| 10:48 ET | 200 | 3.885 |
| 10:50 ET | 5705 | 3.875 |
| 10:51 ET | 500 | 3.875 |
| 10:53 ET | 6558 | 3.865 |
| 10:55 ET | 2300 | 3.865 |
| 10:57 ET | 35197 | 3.875 |
| 11:00 ET | 5487 | 3.895 |
| 11:02 ET | 600 | 3.905 |
| 11:04 ET | 620 | 3.9099 |
| 11:06 ET | 2556 | 3.91 |
| 11:08 ET | 682 | 3.91 |
| 11:09 ET | 100 | 3.91 |
| 11:11 ET | 300 | 3.91 |
| 11:13 ET | 400 | 3.91 |
| 11:15 ET | 200 | 3.91 |
| 11:18 ET | 5958 | 3.93 |
| 11:20 ET | 600 | 3.925 |
| 11:22 ET | 1002 | 3.9223 |
| 11:24 ET | 900 | 3.93 |
| 11:26 ET | 1128 | 3.93 |
| 11:27 ET | 1300 | 3.93 |
| 11:29 ET | 100 | 3.93 |
| 11:31 ET | 12390 | 3.9 |
| 11:33 ET | 3105 | 3.915 |
| 11:36 ET | 520 | 3.92 |
| 11:38 ET | 500 | 3.92 |
| 11:40 ET | 300 | 3.92 |
| 11:42 ET | 1894 | 3.92 |
| 11:44 ET | 2980 | 3.93 |
| 11:45 ET | 1200 | 3.925 |
| 11:47 ET | 16643 | 3.945 |
| 11:49 ET | 300 | 3.95 |
| 11:51 ET | 311 | 3.95 |
| 11:54 ET | 755 | 3.95 |
| 11:56 ET | 17396 | 3.935 |
| 11:58 ET | 1292 | 3.935 |
| 12:00 ET | 1000 | 3.935 |
| 12:02 ET | 5424 | 3.925 |
| 12:03 ET | 1200 | 3.925 |
| 12:05 ET | 1772 | 3.935 |
| 12:07 ET | 1100 | 3.94 |
| 12:09 ET | 8794 | 3.95 |
| 12:12 ET | 14265 | 3.935 |
| 12:14 ET | 2593 | 3.93 |
| 12:16 ET | 200 | 3.935 |
| 12:18 ET | 3600 | 3.925 |
| 12:20 ET | 3121 | 3.925 |
| 12:21 ET | 100 | 3.925 |
| 12:23 ET | 2250 | 3.94 |
| 12:25 ET | 525 | 3.94 |
| 12:27 ET | 3052 | 3.95 |
| 12:30 ET | 300 | 3.95 |
| 12:32 ET | 1885 | 3.955 |
| 12:34 ET | 4334 | 3.955 |
| 12:36 ET | 5331 | 3.985 |
| 12:38 ET | 200 | 3.985 |
| 12:39 ET | 5593 | 4 |
| 12:41 ET | 8369 | 3.98 |
| 12:43 ET | 3065 | 3.98 |
| 12:45 ET | 2000 | 3.9884 |
| 12:48 ET | 7200 | 3.99 |
| 12:50 ET | 800 | 3.99 |
| 12:52 ET | 20936 | 4.005 |
| 12:54 ET | 3745 | 4.02 |
| 12:56 ET | 13641 | 4.04 |
| 12:57 ET | 1942 | 4.045 |
| 12:59 ET | 11789 | 4.025 |
| 01:03 ET | 551 | 4.025 |
| 01:06 ET | 4790 | 4.015 |
| 01:08 ET | 6109 | 4.015 |
| 01:10 ET | 632 | 4.015 |
| 01:12 ET | 600 | 4.02 |
| 01:14 ET | 2227 | 4.025 |
| 01:15 ET | 4356 | 4.015 |
| 01:17 ET | 1397 | 4.015 |
| 01:19 ET | 2759 | 4.02 |
| 01:21 ET | 2331 | 4.03 |
| 01:24 ET | 5937 | 4.025 |
| 01:26 ET | 4489 | 4.01 |
| 01:32 ET | 24200 | 4.005 |
| 01:33 ET | 40504 | 4.06 |
| 01:35 ET | 6389 | 4.055 |
| 01:37 ET | 988 | 4.06 |
| 01:39 ET | 838 | 4.055 |
| 01:42 ET | 1604 | 4.06 |
| 01:44 ET | 6599 | 4.055 |
| 01:46 ET | 25207 | 4.02 |
| 01:48 ET | 10880 | 4.01 |
| 01:50 ET | 1835 | 4.005 |
| 01:51 ET | 900 | 4.015 |
| 01:53 ET | 926 | 4.015 |
| 01:55 ET | 1058 | 4.015 |
| 01:57 ET | 2905 | 4.03 |
| 02:00 ET | 2578 | 4.03 |
| 02:02 ET | 7568 | 4.02 |
| 02:04 ET | 1400 | 4.025 |
| 02:06 ET | 2282 | 4.03 |
| 02:08 ET | 2000 | 4.02 |
| 02:09 ET | 1251 | 4.015 |
| 02:11 ET | 1427 | 4.015 |
| 02:13 ET | 3190 | 4.005 |
| 02:15 ET | 14680 | 3.9991 |
| 02:18 ET | 756 | 3.995 |
| 02:20 ET | 8064 | 3.975 |
| 02:22 ET | 3214 | 3.98 |
| 02:24 ET | 358 | 3.981 |
| 02:26 ET | 1078 | 3.985 |
| 02:27 ET | 8765 | 3.995 |
| 02:29 ET | 6566 | 4 |
| 02:31 ET | 700 | 3.995 |
| 02:33 ET | 5627 | 3.98 |
| 02:36 ET | 2123 | 3.985 |
| 02:38 ET | 2089 | 3.985 |
| 02:40 ET | 3446 | 3.985 |
| 02:42 ET | 840 | 3.985 |
| 02:44 ET | 4350 | 3.99 |
| 02:45 ET | 300 | 3.99 |
| 02:47 ET | 452 | 3.99 |
| 02:49 ET | 13695 | 3.975 |
| 02:54 ET | 1404 | 3.98 |
| 02:56 ET | 1716 | 3.98 |
| 02:58 ET | 704 | 3.975 |
| 03:00 ET | 4576 | 3.975 |
| 03:02 ET | 7435 | 3.96 |
| 03:03 ET | 2914 | 3.935 |
| 03:05 ET | 2953 | 3.935 |
| 03:07 ET | 9496 | 3.92 |
| 03:09 ET | 1168 | 3.925 |
| 03:12 ET | 3300 | 3.935 |
| 03:14 ET | 2186 | 3.935 |
| 03:16 ET | 3486 | 3.94 |
| 03:18 ET | 352 | 3.935 |
| 03:20 ET | 1816 | 3.945 |
| 03:21 ET | 552 | 3.945 |
| 03:23 ET | 523 | 3.945 |
| 03:25 ET | 3304 | 3.935 |
| 03:27 ET | 7058 | 3.925 |
| 03:30 ET | 1094 | 3.925 |
| 03:32 ET | 1404 | 3.925 |
| 03:34 ET | 5094 | 3.94 |
| 03:36 ET | 11727 | 3.925 |
| 03:38 ET | 5234 | 3.93 |
| 03:39 ET | 6864 | 3.915 |
| 03:41 ET | 29210 | 3.89 |
| 03:43 ET | 4173 | 3.915 |
| 03:45 ET | 6731 | 3.93 |
| 03:48 ET | 5620 | 3.92 |
| 03:50 ET | 43971 | 3.885 |
| 03:52 ET | 27832 | 3.895 |
| 03:54 ET | 8003 | 3.91 |
| 03:56 ET | 34493 | 3.895 |
| 03:57 ET | 20961 | 3.895 |
| 03:59 ET | 142766 | 3.88 |
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 11, 2024
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors, from 4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 10, 2024
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum, from 7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 2.7B | -2.5x | --- |
Apogee Therapeutics Inc | 2.8B | -28.2x | --- |
MoonLake Immunotherapeutics | 2.7B | -54.8x | --- |
CG Oncology Inc | 2.9B | -40.6x | --- |
Janux Therapeutics Inc | 2.9B | -41.8x | --- |
Geron Corp | 2.4B | -12.8x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 701.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.15 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
